Lv4
626 积分 2025-01-21 加入
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison
16天前
已完结
Application of hepatic artery interventional therapies in the conversion treatment of unresectable hepatocellular carcinoma: A systematic review and meta-analysis
17天前
已完结
Recent advances in metabolism and toxicity of tyrosine kinase inhibitors
17天前
已完结
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials
18天前
已完结
Application of hepatic artery interventional therapies in the conversion treatment of unresectable hepatocellular carcinoma: A systematic review and meta-analysis
18天前
已完结
Immunotherapy for hepatocellular carcinoma
18天前
已完结
The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review
23天前
已完结
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
24天前
已完结
Pathologic Complete Response after Chemotherapy with Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma with Tumor Thrombus in the Main Portal Trunk
24天前
已完结
The potential efficacy of atezolizumab plus bevacizumab treatment for hepatocellular carcinoma patients with macroscopic portal vein tumor thrombus
24天前
已完结
皖公网安备34019202002308
